If you can't find what you were looking for, please contact us using one of the methods below so we can better serve you.
In response to the recent nationwide shortage of IV solutions, triggered by unexpected damages at key manufacturing sites due to Hurricane Helene, we wanted to assure you of our unwavering commitment to your needs during this challenging period.
Ascorbic Acid Injection (vitamin C) is one of the vital therapies that has been used for decades to address severe vitamin C deficiency and other medical conditions.
McGuff is committed to preserving patient access to Ascorbic Acid Injection. This article outlines the historical highlights of ASCOR, the original FDA-approved Ascorbic Acid Injection, showcasing our steadfast commitment.
Great news - after three years of being on manufacturer back order, we now have 50% Dextrose Injection, USP available in stock.
New Facility Allows for Greater Capacity of Pharmaceutical Manufacturing in the U.S.
On June 18th, the California Board of Pharmacy (CA BOP) held a regulation hearing on compounded drug preparations. McGuff’s management team, along with an estimated attendance of over 100 people, including medical professionals from diverse specialties, attended this three-hour subcommittee meeting. Their goal was to advocate for continued access to sterile compounded drugs from 503A compounding pharmacies.
We’ve been transitioning our 503A compounding pharmacy to a 503B outsourcing facility and are developing many compounded drugs for when we launch, as well as investigating others to develop in the future.
Good news - we now have three testosterone injection products available in stock!
We want to assure our customers that we can safely and effectively ship ASCOR® ascorbic acid injection (vitamin C) unrefrigerated, without ice packs in the shipment packaging, in these warm summer months.
If you receive ASCOR vials warm or even hot, please read the following technical details.
The plastic syringe market has been negatively impacted by the FDA warnings about syringes manufactured in three specific factories in China. This widespread issue is causing supply chain shortages and delays due to increased demand for safe devices.
The good news is that McGuff has ample inventory of both BD and EXEL plastic syringes which are not included in the FDA’s safety alerts.
McGuff has three newly licensed company Designated Representatives, which brings our total to eight.
California State Board of Pharmacy licensed Designated Representatives play a crucial role in the distribution of dangerous drugs or devices. Designated Representatives must have two years of hands-on experience and pass a rigorous state law examination to ensure the safe and compliant distribution of drugs and devices from McGuff Medical Products throughout California and the United States.
McGuff Company is LegitScript Certified
Due to the Coronavirus (COVID-19) outbreak worldwide, the global demand for some Personal Protective Equipment (PPE) is exceeding current supply availability.
In addition, the manufacturing of the PPE and many other wound care/infection prevention products have been impacted by the global response to the Coronavirus. While you may see product availability reduction in the near-term, please be assured that we at McGuff Medical are continuing to work diligently to ensure an uninterrupted supply of products and alternative products to you.
Additionally, in order to ensure healthcare providers have access to the PPEs they need, the McGuff Company is temporarily limiting PPEs to healthcare providers.
As always, please feel free to reach out to our McGuff Customer Service team with any questions that you may have.